XDNA.TO
iShares Genomics Immunology and Healthcare Index ETF
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 7.7 M
ASSETS UNDER MGMT
39 bp
EXPENSES
Fund Basics
| Inception date | Apr 26, 2022 |
| Regulation | |
| Fund Website | link... |
| Distributions | |
| Currency | CAD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| REVOLUTION MEDICINES, INC. | 7.1 % |
| MODERNA, INC. | 6.8 % |
| IPSEN | 5.3 % |
| TAKEDA PHARMACEUTICAL CO LTD | 4.5 % |
| EXELIXIS INC | 4.4 % |
| BAYER AG | 4.4 % |
| MERCK & CO. INC. | 4.3 % |
| GSK PLC | 4.0 % |
| ROCHE HOLDING AG ORDINARY SHARES NEW | 4.0 % |
| REGENERON PHARMACEUTICALS | 3.8 % |
Constituent Breakdown
| Number of holdings | 64 |
| Herfindahl-Hirschman Index | 366 |
| Wgt avg mkt cap (mns) | $36,644 |
| Large cap (>$10bn) | 62.0% |
| Mid cap ($2-10bn) | 9.8% |
| Small cap (<$2bn) | 17.7% |
| Developed mkts. | 89.0% |
| Emerging mkts. | 0.5% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 55.3 % |
 |
FRANCE | 9.1 % |
 |
GERMANY | 8.0 % |
 |
JAPAN | 6.7 % |
 |
BRITAIN | 4.0 % |
 |
DENMARK | 3.2 % |
 |
SWITZERLAND | 1.7 % |
 |
CANADA | 1.1 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 14.6% | 47.3% | 13.3% | 8.9% | -- | -- | -- | 1.6% |
| Dividend Yield | 0.0% | 0.8% | 0.5% | 0.4% | -- | -- | -- | 0.4% |
| Total Returns | 14.6% | 48.1% | 13.8% | 9.3% | -- | -- | -- | 2.0% | Ann. Volatility | 26.5% | 24.6% | 23.7% | 23.2% | -- | -- | -- | 25.3% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.50 | 6% |
| MSCI EAFE | 0.37 | 5% |
| MSCI Emg Mkts | 0.23 | 3% |
Liquidity Measures
| Avg. volume (000) | 1 |
| ADV traded (mns) | $0 |
| Turnover | 0.6% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $42.09 |
| Relative strength (RSI) | 53 |
| MACD/Signal | 0.04/-0.06 |
| Bollinger Bands (Upper/Lower) | $43.02/$40.66 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. XDNA.TO |
Expenses vs. XDNA.TO |
ALTAR Score™ vs. XDNA.TO |
|---|---|---|---|---|
| TDOC.TO | TD Global Healthcare Leaders Index ETF | 13.7% | -4 bp | +8.7% |
| HHL.TO | Harvest Healthcare Leaders Income ETF | 11.8% | +46 bp | +8.2% |
| MHCD.TO | Middlefield Healthcare Dividend ETF | 11.5% | +46 bp | +7.0% |
Risk and Returns: XDNA.TO vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (CAD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/18/2026
Peer Group Comparison
Sample data. Subscribe for access.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
-1.5%
ALTAR SCORE™
1st
PERCENTILE
AVOID
ETFRC RATING
There are 731 funds in the Global Equity category with an average
ALTAR Score™ of 4.3% and a standard deviation
of 2.6%. XDNA.TO's ALTAR Score™ is approximately -2.2 standard
deviations above the category average. This places XDNA.TO in the 1st percentile
among funds in the category.
Sell-Side Consensus
$49.14
PRICE TARGET
+12.2%
UPSIDE